CLINICAL_TRIALS trial_result · 2022-06-28

Clinical Trial Update: Phase II Trial of Continuation Therapy in Advanced NSCLC [Phase 2]

Phase II trial update on continuation therapy for advanced non-small cell lung cancer has completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Greg Durm, MD | Conditions: Non-Small-Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2022-06-28